CLDX CELLDEX THERAPEUTICS
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 17 analyst firms say about CELLDEX THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
15 rated views · 17 analyst/firm records · 17 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8073
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8058
Recent analyst activity · last 90 days
Our tracked history has 9 reports on CLDX from 7 analyst firms in the last 90 days (17 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target, 4 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Morgan Stanley raised its target from $50.00 (set 10 Sep 2026) to $57.00 on 23 Sep 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Barclays | Etzer Darout | Buy | 7 Aug 2026 | 53.00 USD |
| Canaccord Genuity | Edward Nash | Buy | 22 Jul 2026 | 60.00 USD |
| Cantor Fitzgerald | Kristen Kluska | Buy | 22 Sep 2026 | 72.00 USD |
| Goldman Sachs | Richard Law | Hold | 23 Jul 2026 | 28.00 USD |
| Guggenheim | Yastin Suneja | Buy | 20 Jul 2026 | 100.00 USD |
| H.C. Wainwright | Joseph Pantginis | Buy | 2 Oct 2026 | 64.00 USD |
| Jefferies | Roger Song | Buy | 1 Jul 2026 | 68.00 USD |
| Leerink Partners | Thomas Smith | Buy | 23 Sep 2026 | 88.00 USD |
| Lifesci Capital | Sam Slutsky | Buy | 15 Jun 2026 | 67.00 USD |
| Morgan Stanley | Judah Frommer | Buy | 23 Sep 2026 | 57.00 USD |
| Stifel | Alex Thompson | — | 22 Sep 2026 | 68.00 USD |
| TD Cowen | Yaron Werber | Buy | 15 Jun 2026 | — |
| UBS | David Dai | Buy | 10 Jun 2026 | 45.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Wells Fargo | Derek C Archila | Buy | 23 Sep 2026 | 72.00 USD |
| Wolfe Research | Andy G Chen | Buy | 23 Mar 2026 | 44.00 USD |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:52 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.